Cecil R. Pace-Asciak – författare
Visar alla böcker från författaren Cecil R. Pace-Asciak. Handla med fri frakt och snabb leverans.
3 produkter
3 produkter
879 kr
Skickas inom 10-15 vardagar
This volume is a compendium of knowledge relating to the biology, pathophysiology, pharmacology, and genetics of lipoxygenases and their products, edited as proceedings of an International Congress held in Malta in the summer of 1997. The aim of the book is to broaden the existing knowledge on lipoxygenases and metabolites and to identify directions for future research. Papers based on the Congress lectures are gathered together here under three general headings: enzymology, molecular biology and biological functions of mammalian lipoxygenases; metabolic regulation of lipoxygenases and lipoxygenase inhibitors; and products of the lipoxygenase pathways and their receptors, which present forward-looking presentations.
553 kr
Skickas inom 10-15 vardagar
This book is a result of the First Conference on Lipoxygenases, held at Malta, May 17th-2l st, 1997. The goal was very ambitious: having lipoxygenases as a focus for distant and diverse experimental approaches, we brought together scientists to discuss and build a consensus on the biological role of lipoxygenases. Although still fuzzy in many details, the Malta conference has shown that a unifying view on lipoxygenases is finally taking shape, and that the experimental evidence of links and conjugations among events OCCUf ing from cell membranes to intracellular compartments and the nucleus is becoming in creasingly convincing. The editors are deeply grateful to Hospital for Sick Children, Toronto, Free Univer sity Berlin, NOAA Sea Grant College Program (U. S. A. ), Schering, Berlin (F. R. G. ), and Cayman Chemicals, Ann Arbor, Michigan (U. S. A. ), for their generous financial support, which was crucial in making the conference a scientific success. The conference received financial support from a number of additional sponsors, and we express our gratitude to Abbott Labs (U. S. A. ), Air Malta (Malta), Ass. Int. Cancer Res. (U. K. ), Biometra (F. R. G. ), Bayer AG (F. R. G. ), IBL Co. (F. R. G. ), Merck Frosst (Canada), Perkin Elmer (F. R. G. ), Scotia Pharmaceuticals (Canada), Searle (U. S. A. ), SPI Chemicals (France), and TOPCRO (Austria).
1 098 kr
Skickas inom 10-15 vardagar
One of the currently most expanding and exciting areas in cardiovascular research is the study of receipt and dispatch of chemical signals by different cell types. Major progress has been made during the last years and a number of intercellular mediators have been structurally identified and their regulation studied. The impressive developments in molecular biology have provided most effective tools, enabling us to understand message generation in much more detail than anyone would have appreciated a couple of years ago. These developments also have a major impact on cardiovascular pharmacology. This involves both the molecular design of new drugs as well as an improved understanding of how established drugs act. Clearly, changes in one mediator system will also affect others and it might be difficult to take out just one factor and to ignore others. This is definitely true for myocardial ischemia where many different mediators are synthesized and released at about the same time, resulting in a complex picture of events and an even more difficult selection of the most appropriate drug therapy.